Eli Lilly and Company

ALIMTA

  1. Home
  2.  / 
  3. J Code
  4.  / ALIMTA – J9305

Manufacturer:

Eli Lilly and Company

Name:

ALIMTA

Category:

J Code

HCPCS:

J9305

NDC(s):

00002-7623-01, 00002-7640-01, 00338-0720-01, 00338-0722-01, 00409-1045-01, 00409-2188-01, 00409-3532-01, 00480-4514-01, 00480-4515-01, 00480-4516-01, 00781-3518-76, 00781-3519-90, 16729-0229-03, 16729-0230-11, 16729-0244-38, 50742-0340-01, 50742-0341-01, 55150-0381-01, 55150-0382-01, 55150-0383-01, 60505-6065-00, 60505-6066-00, 60505-6067-00, 60505-6068-00, 63323-0134-10, 63323-0450-50, 63323-0621-00, 63323-0622-00, 68001-0535-41, 68001-0536-41, 68001-0538-41, 68001-0539-41, 68001-0543-41, 68001-0544-41, 68001-0550-41, 68001-0551-41, 70710-1654-01, 70710-1655-01, 70710-1674-01, 71288-0166-10, 71288-0167-50, 43598-0386-62, 70860-0202-10, 43598-0387-11, 70860-0203-50, 43598-0370-74,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

ALIMTA is a Cancer drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The J Code: J9305 is aligned to the drug ALIMTA.

Access Pricing and More By Registering